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Abstract
We measured the concentration of three immunoglobulin classes of rheumatoid factors (Ig-RFs),
C3d binding IgG immune complex (C3d-IC), Clq binding IgG immune complex (Clq-IC) and
C-reactive protein (CRP) in 74 samples of human sera with high levels of RF (24.0-2350.0 IU/mI).
In sera with high levels of C3d-IC (> 15.0,ug/ml), there was a positive correlation between the levels
of CRP and the IgG-RF, but there was no correlation between the levels of CRP and the immune
complexes (C3d-IC and Clq-Ie). And then, there was a positive correlation between the levels of
CRP and IgG-RF or C3d-IC and IgG-RF when the levels of Clq-IC in patients sera were higher than
80.0 ,ug/ml. However, there was no correlation between the levels of CRP and Clq-IC in these
patients sera containing high levels of both C3d-IC and Clq-Ie. These results indicated that the
determination of C3d-IC, Clq-IC, IgG-RF and CRP in human sera containing RF denote different
implications as inflammatory indexes on progression of rheumatoid arthritis and other autoimmune
diseases.
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INTRODUCTION
Rheumatoid factors (RF) are autoantibodies
capable of binding to Fc region of denatured
IgG and a little number of native IgG, and are
present in the bloods and synovial fluids of the
most patients with rheumatoid arthritis and
other autoimmune diseases1•2). A number of
previous studies have noted an association
between immune complexes (IC) containing RF
and self-associating IgG in sera and synovial
fluids of rheumatoid arthritis patients and other
autoimmune diseases3 - 5).
Measurements of IC in sera and synovial
School of Health Sciences Okayama University
fluids has been used as a marker for disease
activity of rheumatoids arthritis. There are
several methods to detect the circulating IC in
sera and synovial fluids. Although, testing for
circulating IC is regarded as useful laboratory
parameter in the differential diagnosis and
management of IC-induced disorders, there is
still an uncertainty with regard to assay sys-
tems used for the demonstration of IC6,7). This
is partly due to difficulties in the reproducibili-
ty and principle limitation of available test
systems for the assessment of soluble IC in
body fluids. As a result, discrepant data were
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reported on the IC level of body fluids in RA
dependent on the method selection.
In this study, we measured the concentration
of Clq binding IgG immune complexes (Clq-IC)
and C3d binding IgG immune complexes (C3d-
IC) in human sera containing RF using sand-
wich enzyme linked immune sorbent assay
(ELISA) with specific monoclonal antibodies
for Clq or C3d, and tested stastically mutual
relation between the rheumatoid factors (total
RF, IgA-RF, IgM-RF, IgG-RF), Clq-IC, C3d-IC
and C-reactive protein in each human sera.
MATERIALS and METHODS
1. Human sera as materials
The 74 samples of human sera containing
rheumatoid factors (total RF with latex
immune agglutination method, Kyowa Medix :
24.0 - 2350.0 IU/ml) are selected for this study.
2. Assay of Immune complexes in human sera
The concentrations of C1q-IC and C3d-IC
were measured with ELISA method using anti-
Clq monoclonal antibody or anti-C3d mono-
clonal antibody respectively (MBL Co. Ltd)
according to the method of Antes U et alB-iO).
3. Assay of Immunoglobulin classes of RF
The values of three immunoglobulin classes
of rheumatoid factors (Ig-RFs; IgA-RF, IgM-
RF and IgG-RF) in human sera were measured
with ELISA method (Immunoeriot· RF for
IgM-RF and IgG-RF, IgA-RF determination
reagent for IgA-RF; Toyobo Co. Ltd).
4. CRP in human sera
The concentration of CRP was measured with
the immunological turbidometric assay (Wako
pure chemicals Inc).
5. Statistical analysis
The data of concentration of total RF, Ig-
RFs, C3d-IC, Clq-IC and CRP in 74 patients
sera were analyzed statiscally by the analysis
of variance technics, and indicated the values of
correlation coefficients (r) and the statiscal
probability (p).
RESULTS
Distribution of data on total RF, Ig-RFs,
C1q-IC, C3d-IC and CRP were shown on Table
1. And then the results of statiscal analysis of
these data of r values and p values appeard on
Table 2. There were slight positive correlation
between the values of CRP and the C3d-IC (r=
0.505, p<0.001; Fig. 1), IgA-RF and C3d-IC (r=
0.493, p<0.001), IgG-RF and C3d-IC (r=0.367,
p<O.01) and high positive correlation between
C3d-IC and Clq-IC (r=0.675, p<0.001 ; Fig. 2)
was recognized. However, there were no corre-
lation between the values of total RF (T-RF)
and the CRP, T-RF and C3d-IC or T-RF and
C1q-IC. And then there were positive
correlation between the levels of T-RF and the
Table 1. Mean and SD values of total RF, CRP, IgA-RF, IgM-RF, IgG-RF, Clq-IC and C3d-IC in all
patients sera.
T-RF CRP IgA-RF IgM-RF IgG-RF Clq-IC C3d-IC
IU/ml ,ug/ml IU/ml IU/ml IU/ml ,ug/ml ,ug/ml
(n=74) (n=74) (n=74) (n=74) (n=74) (n=74) (n=50)
mean 151.87 11.27 22.67 159.49 62.55 35.59 0.92!VI
!VI 66.35 2.03 4.56 49.85 18.54 12.48 0.03
± - - - - - - -
SD 347.58 62.68 112.62 510.30 573.64 101.49 34.09
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Table 2. The values of coefficients correlation (r) and the significant probability (p) in all patients sera.
T-RF CRP Clq-IC C3d-IC IgA-RF IgM-RF IgG-RF
T r~ 0.090 0.067 0.207 0.608 0.565 0.612RF ~p N. S N. S N. S <0.001 <0.001 <0.001
C r 0.090 ~ 0.139 0.505 0.404 0.373 0.293R ~P p N. S N. S <0.001 <0.001 <0.001 <0.01
Cl r 0.067 0.139 ~ 0.675 0.184 0.043 0.186q ~IC p N. S N. S <0.001 N. S N. S N. S
C3 r 0.207 0.505 0.675 ~ 0.493 0.278 0.367d ~IC P N. S <0.001 <0.001 <0.001 <0.05 <0.01
Ig r 0.608 0.404 0.184 0.493 ~ 0.713 0.644A ~RF p <0.001 <0.001 N. S <0.001 <0.001 <0.001
Ig r 0.565 0.373 0.043 0.278 0.713 ~ 0.662M ~RF p <0.001 <0.001 N. S N. S <0.001 <0.001
Ig r 0.612 0.293 0.186 0.367 0.644 0.662 ~G ~RF p <0.001 <0.01 N. S <0.01 <0.001 <0.001
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Fig. 1. Significant" correlation between the concentra-
tion of C3d-IC and the CRP in patients sera.
Y=0.26X+2.17, r=0.505, p<O.OOl, n=50.
OI-<!_1~.0-r---r--r-~---:3::c.O=--.,....--.-.....-----.---l7.
C3d·IC ( log x !!g/ml)
Fig. 2. Significant correlation between the concentar-
tion of C3d-IC and the Clq-IC in patients sera.
Y=0.16X+3.94, r=0.675, p<O.OOl, n=50.
-73 -
Ig-RFs (T-RF: IgA-RF, r=0.608, p<O.OOl.
T-RF: IgM-RF, r=0.565, p<O.OOl. T-RF: IgG-
RF, r=0.612, p<O.OO1).
When the concentration of C3d-IC was higher
than 15.0,ug/ml (n=20), there was positive cor-
relation between CRP and IgG-RF (r=0.630,
p<O.OO1; Fig. 3). And also, when the concentra-
tion of Clq-IC was higher than 80.0 ,ug/ml (n=
16), there were positive correlation between the
levels of CRP and the IgG-RF (r = 0.606, p < 0'0.0 5-0
IgG-RF ( log x IUlml)
10·0
•
•
•
o.Q:!:-r---.----.,r---.----='-:---r---.-"'T"""_---i
0.0 5.0 10.0
IgG-RF ( log x IU/ml)
Fig. 3. Significant correlation between the concentra-
tion of CRP and the IgG-RF in patients sera
containing high levels of C3d-Ie. (C3d-IC; > 15.
OJlg/ml, n=20)
Y=0.51X+0.81, r=0.598, p<0.005.
O.00.j...O......l.~....,.--.--....,.--r5...,...0---.--r-----;,..--r----l10.0
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Fig. 4. Significant correlation between the concentra-
tion of CRP and the IgG-RF in patients sera
containing high levels of Clq-Ie. (Clq-IC; >80.
OJlg/ml, n = 16)
Y=0.74X-0.47, r=0.607, P<O.Ol.
Fig. 5. Significant correlation between the concentra-
tion of C3d-IC and the IgG-RF in patients sera
containing high levels of Clq-Ie. (Clq-IC; >80.
0Jlg/ml, n=16)
Y=0.55X+0.52, r=0.655, P<0.005.
0.01; Fig.4), and between C3d-IC and IgG-RF
(r=0.655, p<0.005; Fig.5). However, there was
no correlation between the levels of CRP and
the Clq-IC in these patients sera containing
high levels of both C3d-IC and the Clq-IC.
DISCUSSION
The pathogenic mechanisms III rheumatoid
arthritis (RA) include humoral and cellular
immunity. The humoral immunity participates
in the pathogenesis of RA through formation of
immune complexes. In patients with RA,
immune complexes have been demonstrated in
circulation, synovial fluids, synovial tissue,
phagocytic cells in the synovial lining and
superficial layers of articular cartilage.. RFs
are abundantly formed in the antigen-antibody
complexes at these locations, indicating their
participation in the inflammatory lesions of
RA.
IgG-RF was initially recognized as constitu-
ents of the intermediate complexes in the serum
of patients with RA. IgG-RF forms immune
complexes by self-association, a unique process
that allows immune complex formation without
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the presence of antigen molecules. The interac-
tion of two IgG-RF molecules is stabilized by
the formation of two antigen-antibody bonds
between them, leaving free antibody combining
sites and free antigenic determinants.
Interaction of IgM-RF with monomeric or
polymeric IgG may lead to formation of
immune complexes of varying sizes in sera and
synovial fluids of patients with RA. The nature
of the immune complexes formed between IgA-
RF and monomeric IgG was not examined.
Thus, IgM-RF and IgG-RF in immune complex-
es can contribute to inflammation by activating
the complement system.
The appearance of CRP in t~e serum is a
nonspecfic response to inflammation, infection,
and tissue damage. CRP which is one of the
"acute phase protein" which of the concentra-
tion are rised in acute phase sera and synovial
fluids of patients with RA. CRP can also bind
to a variety of ligands of autogenous orgin
including phospholipids, nonphospholipids,
polyanion and polycations. A major function of
CRP may be to recognize such autogenous
materials in the plasma following tissue dam-
age and to detoxify them for their rapid clear-
ance. Because of the ability of aggregated or
complexed human CRP to activate the classical
complement pathway, it was also raised as a
possibility that CRP could enhance inflamma-
tion and tissue damage. Complexed human
CRP activated the first component of human
complement to bind the N-terminalof Clq
molecules1!).
Our previous studies demonstrated the high
correlation between the levels of total RF (mea-
sured with RAPA) and Ig-RFs (ELISA) in
human sera (r=0.90)12.13). In this study, we
confirmed high correlation between the levels
of total RF (Latex Immuno turbidometric
assay) and the IgG-RF (r=0.612). There was
some positive correlation between the levels of
IgG-RF and the C3d-IC (data not shown), but
not between the IgG-RF and Clq-IC for 74
samples. However there was no correlation
between the levels of C3d-IC and the IgG-RF in
patients sera containing high levels of C3d-IC,
on the contrary, there was positive correlation
between the levels of C3d-IC and the IgG-RF in
the patients sera containing high levels of CIq-
Ie. In addition, there was positive correlation
between the levels of C3d-IC and the CRP for 74
samples, but no correlation between the C3d-IC
and the CRP in the patients sera containing
high levels of C3d-IC and Clq-IC (data not
shown). These results indicated that the deter-
mination of C3d-IC, Clq-IC, IgG-RF and CRP in
human sera shows different implications as
inflammatory indexes on progression of
rheumatoid arthritis14- 16). The results indicate
if when we detect the high levels of C3d-IC and
the Clq-IC in patients sera, caution should be
exercised to evaluate the concentration of CRP
in such cases. The above date are conformed
well to the study of Watanabe et all7), that
support the usefulness of C3d-IC and IgG-RF
measurements for the prediction of progressive
disorder in RA. These observations suggest the
necessity of measuring the levels of C3d-IC,
Clq-IC, IgG-RF and CRP at the same time in
patients sera and synovial fluids of RA.
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リウマチ因子陽性ヒト血清中の免疫グロブリンGクラスリウマチ因子と
免疫複合体ならびにCRPとの相関性
唐下博子 -村光子 崎山順子 森 秀治 中田安成 遠藤 浩
要 約
一般に慢性関節)ウマテの診断ならびに活動性の-指標として,日常臨床検査では患者血清中のリウ
マチ因子の測定が実施されている｡
本論文ではRF検査依頼が有 り,高 RF値 (24.0-2350.OIU/ml)を示した患者血清74検体につい
て,免疫グロブリンクラス別 RF値を測定するとともに自己IgG と補体 との免疫複合体 (IC)であるCl
q-IgG･IC (Clq-IC),C3d｣gG･IC (C3d-1C)ならびにCRP値を測定し,それらの測定値間の相関性
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について統計学的検討を行った｡C3d-IC値が15.0/Jg/ml以上の高値を示す患者血清では,CRP値と
IgGクラスのRF(IgG-RF)借間については正の相関結果が得られた｡また,Clq-IC値が80.0/Jg/ml以
上の場合にもCRP値とIgG-RF借間およびC3d-IC値とIgG-RF借間では正の相関結果が得られた｡
しかし,C3d-ICならびにClqJCともに高値例の患者血清中のCRP値とClq-IC借間には有意な相関
は観察されなかった｡以上の結果より,慢性関節リウマチの活動度を判定する上で,従来から炎症マ-
カーとしてCRP値が利用されているが,血清中に免疫複合体が高レベルに検出される患者については,
炎症の指標としてCRP以外にもClq-1Cや C3d-ICおよびIgG-RF等を加えた稔合的な判断が必要で
あることが示唆される｡
キーワード:自己IgG結合性リウマチ因子,Clq結合IgG免疫複合体,C3d結合IgG免疫複合体,
C反応性タンパク質 (CRP)
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